Prescription drug utilization review in the private sector

John Kralewski, Albert Wertheimer, Edward Ratner

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

With increased coverage of prescription drugs by health insurance plans, utilization data are now becoming available and there is renewed interest in drug utilization review (DUR) programs. This article describes the DUR programs now being conducted by private sector firms for health insurance plans. The programs were found to be highly automated and very efficient. Most firms estimate at least two to three dollar direct savings for each dollar invested in DUR. Much of this results from controlling overutilization and gaining compliance with drug formulary guidelines. In addition, the firms report finding drug therapy problems in about two to three percent of the enrollees receiving prescriptions.

Original languageEnglish (US)
Pages (from-to)62-71
Number of pages10
JournalHealth Care Management Review
Volume19
Issue number2
DOIs
StatePublished - Jan 1 1994

Keywords

  • Prescription drug utilization review

Fingerprint

Dive into the research topics of 'Prescription drug utilization review in the private sector'. Together they form a unique fingerprint.

Cite this